Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLegal & General Regulatory News (LGEN)

Share Price Information for Legal & General (LGEN)

Share Price is delayed by 15 minutes
Get Live Data
290.30    0.20 (0.07%)
Bid:
290.20
Ask:
290.40
Spread: 0.20 (0.069%)
Market Cap: £15.87b
LGEN Live PriceLast checked at - London Stock Exchange

Intraday Legal & General Share Chart

Directorate Change

17 Jun 2022 07:00

RNS Number : 2184P
Legal & General Group Plc
17 June 2022
 

 

Legal & General Group Plc Board announces the appointment of Carolyn Johnson as a non-executive director of Legal & General Group Plc

 

 

17 June 2022

 

The Board of Legal & General Group Plc (the "Company") is pleased to announce the appointment of Carolyn Johnson as an independent non-executive director of the Company with immediate effect. Carolyn will join the Group Audit, Group Risk and Group Nominations and Corporate Governance Committees upon appointment.

 

Carolyn has extensive knowledge of the insurance and financial services industries following a 30-year executive career in the United States. In particular, she has deep experience in the life insurance market, having held senior roles at AIG, Voya Financial and Protective Life Corporation.

 

Carolyn Johnson was a director of Majesco, Inc until 2020. There is no other additional information required to be disclosed in relation to Carolyn Johnson pursuant to LR 9.6.13R of the Listing Rules of the Financial Conduct Authority.

 

Sir John Kingman, Group Chairman, said:

 

"I am delighted to welcome Carolyn to the Group Board. Carolyn brings with her a wealth of experience in insurance and in financial services more generally. Her appointment will strengthen the Board's engagement with our successful and growing US businesses in life insurance, asset management and pension risk transfer. I very much look forward to working with her."

 

In addition, the Board of the Company is pleased to annouce that Laura Wade-Gery will become chair of the Group Technology Committee with effect from 1 September 2022.

 

Laura Wade-Gery joined the Board on 3 January 2022 as a non-executive director and is a member of the Group Technology Committee and Group Nominations and Corporate Governance Committee.

 

Notes to Editors

Legal & General Group Plc

 

Established in 1836, Legal & General is one of the UK's leading financial services groups and a major global investor, with over £1.4 trillion in total assets under management of which a third is international. L&G also provides powerful asset origination capabilities. Together, these underpin our leading retirement and protection solutions: we are a leading international player in pension risk transfer, in UK and US life insurance, and in UK workplace pensions and retirement income. As at 16 June 2022, Legal & General has a market capitalisation of £14.6 billion.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAMZGMVGVDGZZZ
Date   Source Headline
15th Mar 202310:00 amRNSAnnual Financial Report
8th Mar 20237:00 amRNSL&G Full Year Results 2022 Part 2
8th Mar 20237:00 amRNSL&G Full Year Results 2022 Part 1
2nd Mar 20235:00 pmRNSDirector/PDMR Shareholding
1st Mar 20235:00 pmRNSDirector/PDMR Shareholding
1st Mar 20235:00 pmRNSTotal Voting Rights
1st Mar 20235:00 pmRNSDirector/PDMR Shareholding
16th Feb 202311:38 amRNSHolding(s) in Company
15th Feb 20231:51 pmRNSHolding(s) in Company
10th Feb 202310:42 amRNSHolding(s) in Company
2nd Feb 20235:00 pmRNSDirector/PDMR Shareholding
1st Feb 20235:00 pmRNSDirector/PDMR Shareholding
1st Feb 20235:00 pmRNSDirector/PDMR Shareholding
1st Feb 20235:00 pmRNSTotal Voting Rights
30th Jan 20237:00 amRNSPlanned retirement of Sir Nigel Wilson
23rd Jan 20237:47 amRNSDirector Declaration
4th Jan 20235:00 pmRNSDirector/PDMR Shareholding
3rd Jan 20235:00 pmRNSTotal Voting Rights
3rd Jan 20235:00 pmRNSDirector/PDMR Shareholding
3rd Jan 20235:00 pmRNSBlock listing Interim Review
3rd Jan 20235:00 pmRNSDirector/PDMR Shareholding
22nd Dec 20225:00 pmRNSDirector/PDMR Shareholding
2nd Dec 20225:00 pmRNSDirector/PDMR Shareholding
1st Dec 20225:00 pmRNSDirector/PDMR Shareholding
1st Dec 20225:00 pmRNSDirector/PDMR Shareholding
1st Dec 20225:00 pmRNSTotal Voting Rights
29th Nov 20221:50 pmRNSIFRS 17 investor and analyst event
18th Nov 20227:00 amRNSTrading Statement
11th Nov 20229:00 amRNSBoard Committee Appointment
7th Nov 20224:31 pmRNSHolding(s) in Company
2nd Nov 20225:00 pmRNSDirector/PDMR Shareholding
1st Nov 20225:33 pmRNSDirector/PDMR Shareholding
1st Nov 20225:31 pmRNSDirector/PDMR Shareholding
1st Nov 20225:30 pmRNSTotal Voting Rights
14th Oct 20229:00 amRNSBoard Committee Appointment
4th Oct 20225:00 pmRNSDirector/PDMR Shareholding
4th Oct 20227:00 amRNSTrading Statement
3rd Oct 20225:00 pmRNSDirector/PDMR Shareholding
3rd Oct 20225:00 pmRNSTotal Voting Rights
3rd Oct 20225:00 pmRNSDirector/PDMR Shareholding
28th Sep 20225:00 pmRNSDirector/PDMR Shareholding
28th Sep 20225:00 pmRNSDirector/PDMR Shareholding
2nd Sep 20225:00 pmRNSDirector/PDMR Shareholding
1st Sep 20225:00 pmRNSDirector/PDMR Shareholding
1st Sep 20225:00 pmRNSDirector/PDMR Shareholding
1st Sep 20225:00 pmRNSTotal Voting Rights
10th Aug 20225:00 pmRNSDirector/PDMR Shareholding
9th Aug 20227:00 amRNSL&G Half Year Results 2022 Part 3
9th Aug 20227:00 amRNSL&G Half Year Results 2022 Part 2
9th Aug 20227:00 amRNSL&G Half Year Results 2022 Part 1

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.